Fatigue is significant in vasovagal syncope and is associated with autonomic symptoms
Open Access
- 10 June 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 10 (9), 1095-1101
- https://doi.org/10.1093/europace/eun164
Abstract
To quantify the prevalence of fatigue and its severity in vasovagal syncope (VVS) and to examine whether fatigue severity associates with symptoms of autonomic dysfunction. All vasovagal syncope patients diagnosed between September 2004 and March 2006 were included ( n = 140). Fatigue was quantified using the fatigue impact scale (FIS) and severity and type of autonomic symptoms by the composite autonomic symptom scale (COMPASS). Patients were considered a ‘responders’ if they were no longer experiencing VVS symptoms or ‘non-responders’ if VVS symptoms were on-going. The VVS cohort was matched, in terms of both age and sex, with a group of community dwelling controls. Ninety-six VVS patients completed questionnaires (response rate 96/140, 69%). Compared with matched controls, VVS patients were significantly more fatigued (26 ± 32 vs. 13 ± 14, P < 0.0001) and a significantly higher autonomic symptom burden (COMPASS total score: 34 ± 23 vs. 13 ± 13; P < 0.0001). Significant correlations were seen between the total COMPASS score and fatigue severity ( r2 = 0.4; P < 0.0001). Non-responders reported significantly higher fatigue and more autonomic symptoms than responders to treatment ( P ≤ 0.0001). Fatigue is a significant problem experienced by patients with VVS and is associated with autonomic symptoms, the severity of which correlates with fatigue severity. These symptoms are especially profound in those who have not responded to treatment.Keywords
This publication has 21 references indexed in Scilit:
- Symptoms of autonomic dysfunction in chronic fatigue syndromeQJM: An International Journal of Medicine, 2007
- The role of psychological factors in response to treatment in neurocardiogenic (vasovagal) syncopeEP Europace, 2006
- Psychiatric profile, quality of life and risk of syncopal recurrence in patients with tilt-induced vasovagal syncopeEP Europace, 2005
- Short-term evolution of vasovagal syncope: Influence on the quality of lifeInternational Journal of Cardiology, 2005
- Evaluation of Orthostatic Hypotension: Relationship of a New Self-report Instrument to Laboratory-Based MeasuresMayo Clinic Proceedings, 2005
- Midodrine treatment for chronic fatigue syndromePublished by Oxford University Press (OUP) ,2004
- Clinical characteristics of patients with vasovagal reactions presenting as unexplained syncopeEP Europace, 2001
- Tilt table testing for assessing syncopeJournal of the American College of Cardiology, 1996
- Evaluation and management of the patient with syncopePublished by American Medical Association (AMA) ,1992
- Impairment of physical and psychosocial function in recurrent syncopeJournal of Clinical Epidemiology, 1991